Yes. Oncoceutics was formerly owned by 1 private investor.
Oncoceutics is headquartered in Philadelphia, Pennsylvania.
Oncoceutics is a life science company.
Oncoceutics was founded in 2009.
3675 Market Street, Suite 200,
Philadelphia, Pennsylvania
19104
United States,
www.oncoceutics.com
Oncoceutics, Inc. is a clinical-stage biotechnology company developing imipridones, a novel class of compounds. Oncoceutics’ lead product candidate, ONC201, has been shown in clinical testing to selectively induce cell death in multiple cancer types. ONC201 is currently in a registrational clinical trial for recurrent H3 K27M-mutant glioma and a confirmatory response rate assessment is expected in 2021. Oncoceutics, Inc. was founded in 2009 and is based in Philadelphia, Pennsylvania.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
